One post from Jaban M Moore's dossier. This page reviews a single piece of material. The full dossier cross-checks 42 materials and carries the verified credential and scope verdicts.
Read the full dossier →https://web.archive.org/web/20260826141623/https://www.youtube.com/watch?v=yT3ENX1G7zo
View dossier →Jaban M Moore alias The Root-Cause Ringleader
YouTube · UCgCDI1l6SF-q_wNG8czQ0nA
Practice location
420 ARMOUR RD
NORTH KANSAS CITY, MO 64116
Funnel-first framing that runs on persuasion, light on published evidence.
- Of 11 health claims, 5 run counter to or conflict with the published evidence, and 1 was not independently checked.
- Primary persuasion tactic: Patient interviews marketed as medical synthesis.
- Stated credentials look inflated relative to the advice given.
- Profits from the products and labs they recommend, with no clear disclosure.
- Gives advice beyond what their license covers.
Jaban Moore has assembled the deluxe chronic-illness cinematic universe: Lyme, mold, autoimmunity, lipedema, stem cells, fertility, and one mysterious pattern that apparently escaped every clinician alive. Then, right on cue, the plot resolves into a booking call with the team.
High grift signals
Score breakdown
Direct answer
Jaban M Moore is licensed in Missouri as a chiropractor (DC), not as an MD or DO, and Missouri's chiropractic scope statute (RSMo § 331.010) limits that license to musculoskeletal care, not the diagnosis or treatment of systemic disease. Even so, they advertise diagnosing or treating Lyme disease, Autoimmune disease, Unspecified non-antibiotic Lyme treatment, Mold-related illness, and Lipedema, conditions that belong with infectious-disease physicians, rheumatologists, and allergy and immunology specialists. Those same pages route patients toward paid programs that Jaban M Moore profits from.
Key findings
- False Authority: Interviewing clinicians and having lived experience does not establish clinical expertise, diagnostic authority, or competence to synthesize treatment decisions for Lyme disease, autoimmune illness, lipedema, fertility, or stem-cell therapy.see section ↓
- Claim "Doctors privately say things they will not say publicly.": not supported by peer-reviewed evidence.see section ↓
- Claim "Stem cell therapy is presented as a chronic-illness treatment option under consideration.": supported by peer-reviewed sources.see section ↓
- NPI registry confirms Jaban Moore as Chiropractor (DC) in Missouri (NPI 1073958815).see section ↓
- Jaban M Moore shows credential inflation relative to stated vs likely credentials.see section ↓
- Dr Jaban M Moore is marketed with a doctor title, but reviewed credentials indicate Chiropractor (DC) rather than an MD/DO physician license.see section ↓
- Against Missouri State Board of Chiropractic Examiners scope rules (RSMo § 331.010), these advertised activities appear outside Jaban M Moore's license (including conditions they merely list as ones they treat): Lyme disease can be healed without antibiotics using an alternative approach., Lyme…see section ↓
- 10 of 10 advertised activities fall outside permitted Chiropractor scope in MO.see section ↓
Claims & evidence
8 advertised conditions or treatments fall outside their license scope. Each box leads with state-board scope notation; literature cross-check follows when we matched a specific claim. Every card carries its receipts: the quoted wording, a live source link, and an archived copy.
Jaban M Moore is not licensed or approved by Missouri State Board of Chiropractic Examiners to advertise Lyme disease can be healed without antibiotics using an alternative approach. as within their scope of practice.
Lyme disease can be healed without antibiotics using an alternative approach.
- Contradicts
- The supplied index papers do not address Lyme disease or alternative treatments: they concern type 1 diabetes, rheumatoid arthritis, angioplasty, medical education, heart failure, mHealth, training, and SCENAR therapy, so none provides evidence for this claim. [1] Standard evidence-based guidance recommends treating confirmed Lyme disease with appropriate antibiotics, with oral or intravenous regimens selected according to disease manifestation. Clinical trials have established the efficacy of doxycycline, amoxicillin, and cefuroxime for Lyme disease, while ceftriaxone is used when parenteral treatment is indicated. [3][4] No high-quality evidence identified supports an alternative, non-antibiotic approach as a reliable cure for Lyme disease. Untreated infection can disseminate and cause neurologic, cardiac, or joint disease, although some early symptoms may fluctuate or resolve temporarily, which does not establish eradication of infection.
- Mainstream view
- Confirmed Lyme disease should be diagnosed and treated with an appropriate antibiotic regimen. [4] Major clinical guidance and public-health recommendations do not endorse replacing antibiotics with alternative approaches. [1][3] Persistent symptoms after recommended treatment require clinical reassessment rather than unproven alternative therapy.
“Why she chose to heal Lyme without antibiotics, and what she used instead”
Rule: RSMo § 331.010
Jaban M Moore is not licensed or approved by Missouri State Board of Chiropractic Examiners to diagnose, treat, or cure Lyme disease.
Lyme disease
- Contradicts
- The supplied index papers do not address Lyme disease or alternative treatments: they concern type 1 diabetes, rheumatoid arthritis, angioplasty, medical education, heart failure, mHealth, training, and SCENAR therapy, so none provides evidence for this claim. [1] Standard evidence-based guidance recommends treating confirmed Lyme disease with appropriate antibiotics, with oral or intravenous regimens selected according to disease manifestation. Clinical trials have established the efficacy of doxycycline, amoxicillin, and cefuroxime for Lyme disease, while ceftriaxone is used when parenteral treatment is indicated. [3][4] No high-quality evidence identified supports an alternative, non-antibiotic approach as a reliable cure for Lyme disease. Untreated infection can disseminate and cause neurologic, cardiac, or joint disease, although some early symptoms may fluctuate or resolve temporarily, which does not establish eradication of infection.
- Mainstream view
- Confirmed Lyme disease should be diagnosed and treated with an appropriate antibiotic regimen. [4] Major clinical guidance and public-health recommendations do not endorse replacing antibiotics with alternative approaches. [1][3] Persistent symptoms after recommended treatment require clinical reassessment rather than unproven alternative therapy.
“Lyme”
Rule: RSMo § 331.010
Jaban M Moore is not licensed or approved by Missouri State Board of Chiropractic Examiners to diagnose, treat, or cure Autoimmune disease.
Autoimmune disease
- Supports
- Licensed, evidence-based treatments exist for many specific autoimmune diseases and manifestations, including corticosteroids, conventional immunosuppressants, biologics, and targeted therapies. [13][15][16] Autoimmune encephalitis reviews describe disease-specific diagnostic and acute-management approaches rather than a single universal treatment. [5][6][8][11][12][14] ANCA-associated vasculitis has established disease-specific treatment strategies. [7] Autoimmune hemolytic anemia also has consensus-based treatment recommendations. [10] Randomized evidence supports efgartigimod for chronic inflammatory demyelinating polyradiculoneuropathy, an autoimmune-mediated disorder. [9]
- Contradicts
- The claim is too broad to establish that one licensed treatment treats autoimmune disease as a general category. [14] Autoimmune diseases comprise many distinct disorders with different mechanisms, organs affected, severity levels, and approved indications. [12][13][16] The cited literature addresses diagnosis or treatment of particular conditions, not a universal licensed treatment for all autoimmune disease. [5][6][10][11][15] Some autoimmune conditions lack a disease-modifying cure, and treatments can have substantial risks requiring specialist diagnosis and monitoring. [7] Misdiagnosis is also documented in autoimmune encephalitis, emphasizing that treatment should not be based on a broad label alone. [8]
- Mainstream view
- The mainstream medical view is that autoimmune disease is a heterogeneous group, not a single treatable condition. [8] Licensed therapies are available for selected named diseases and clinical manifestations, but treatment must be individualized according to the confirmed diagnosis, affected organs, disease activity, comorbidities, and risks. [5][6][7][10][11][12][15][16] The phrase "licensed treatment of Autoimmune Disease" is therefore clinically incomplete and should not be interpreted as a claim of one licensed therapy for autoimmune disease generally. [13][14]
“autoimmune specialists”
Rule: RSMo § 331.010
Jaban M Moore is not approved to offer Stem cell therapy is presented as a chronic-illness treatment option under consideration. within a Chiropractor scope of practice under Missouri State Board of Chiropractic Examiners.
Stem cell therapy is presented as a chronic-illness treatment option under consideration.
No specific health claims of theirs were cross-checked against the literature.
“The stem cell therapy decision — not the results, but the fear and uncertainty before she committed”
Rule: RSMo § 331.010
Jaban M Moore is not licensed or approved by Missouri State Board of Chiropractic Examiners to diagnose, treat, or cure Mold-related illness.
Mold-related illness
- Supports
- Mold exposure is a recognized cause or aggravating factor for specific conditions, including allergic rhinitis, asthma exacerbations, respiratory irritation, hypersensitivity pneumonitis, and rare invasive fungal infections in people with substantial immune compromise. [21] The WHO recommends preventing and remediating persistent dampness and mold because remediation may reduce respiratory and asthma-related adverse outcomes. [22][23][24] The listed index papers do not provide relevant evidence because they concern unrelated clinical trials .
- Contradicts
- The phrase licensed treatment of mold-related illness does not identify a specific diagnosis, treatment, mechanism, or outcome. [21] There is no single universally accepted disease entity called mold-related illness encompassing nonspecific systemic symptoms, and evidence does not establish that one licensed treatment treats such a broad condition. Evaluation should instead identify a specific condition, such as asthma, allergy, hypersensitivity pneumonitis, or invasive fungal infection, for which standard disease-specific management applies. Routine mold testing of buildings or nonspecific mold-directed therapies are not broadly recommended by public-health guidance.
- Mainstream view
- Mold and damp indoor environments can cause or worsen certain well-defined respiratory, allergic, and immune-mediated diseases, and rare invasive fungal infections require specialist antifungal treatment. [21][22][23][24] The mainstream approach is clinical diagnosis of the specific condition, exposure reduction and remediation of dampness, and guideline-based treatment; it does not recognize a generic mold-related illness with a single licensed treatment.
“mold doctors”
Rule: RSMo § 331.010
Jaban M Moore is not licensed or approved by Missouri State Board of Chiropractic Examiners to diagnose, treat, or cure Lipedema.
Lipedema
- Supports
- Diet and exercise can affect clinically important aspects of lipedema, particularly mobility, function, pain, edema, and leg volume when coexisting overweight or obesity is present. The 2024 S2k guideline recommends nutrition and weight management to preserve or recover mobility and functionality and help prevent disease progression, and states that leg volume can be reduced by weight reduction in patients with overweight or obesity. [17][20] The same guideline includes movement or a training program in the overall treatment concept for pain relief and reports that water-based exercise may help. [19] A small case series of five women with lipedema and insulin resistance found that exenatide, sometimes combined with diet or physical activity, was associated with reduced lipedema symptoms, pinching pain, and subcutaneous adipose-tissue thickness, although this was uncontrolled and preliminary.
- Contradicts
- The claim is contradicted by guideline recommendations that diet, exercise, and weight management can improve function, pain, edema-related outcomes, and leg volume in relevant patients. [20] GLP-1 medications reliably cause substantial weight loss in obesity trials, but those trials generally did not establish that GLP-1 drugs specifically reduce lipedema fat or alter lipedema progression. The direct lipedema evidence is limited to very small uncontrolled case evidence, so it cannot establish efficacy or generalize to all patients. The listed index papers are unrelated clinical-trial registrations and provide no evidence about lipedema, GLP-1 medications, diet, or exercise.
- Mainstream view
- Lipedema is not expected to resolve simply through weight loss, and affected adipose tissue may be relatively resistant to conventional weight reduction. However, saying that GLP-1 medications, diet, and exercise will not affect lipedema is too absolute. Diet and exercise are recommended for associated overweight or obesity and can improve mobility, functionality, pain, edema, and sometimes limb volume; they may not selectively eliminate all lipedematous fat. GLP-1 medications are established treatments for obesity and metabolic disease, but their lipedema-specific benefits remain investigational, with only preliminary case-series evidence and no high-quality randomized trials demonstrating modification of lipedema itself. [17][19]
“lipedema surgeons”
Rule: RSMo § 331.010
Jaban M Moore is not approved to offer Stem cell therapy within a Chiropractor scope of practice under Missouri State Board of Chiropractic Examiners.
Stem cell therapy
- Supports
- Some stem cell-based interventions are licensed or approved for specific diseases and tightly defined indications, especially hematopoietic stem-cell transplantation and certain engineered or gene-modified cell therapies. [33][34][36] The TRANSFORM trial supports lisocabtagene maraleucel, a CAR T-cell therapy manufactured from a patient's T cells rather than a generic stem-cell treatment, for selected patients with relapsed or refractory large B-cell lymphoma. [25][31][32][35] Lentiviral hematopoietic stem-cell gene therapy has shown long-term benefit in selected children with early-onset metachromatic leukodystrophy in a non-randomized phase 1/2 study. [26] Reviews describe real clinical promise but emphasize that pluripotent stem-cell therapies remain limited by safety, manufacturing, and efficacy challenges. [27][29] A randomized phase 2a trial has evaluated allogeneic mesenchymal stem cells in mild Alzheimer's disease, but this represents investigational evidence for a particular product and condition, not validation of stem-cell therapy generally. [28]
- Contradicts
- The claim is too nonspecific to establish that any particular stem-cell treatment is licensed, for which disease, in which jurisdiction, or with what evidence. [25][33][34][36] The index literature includes clinical trials, reviews, transplantation-related treatments, and CAR T-cell therapy rather than evidence that generic stem-cell therapy is a licensed treatment. [26][32][35] A 2025 review describes many ongoing clinical trials and a limited number of approved products, underscoring that approval is product- and indication-specific rather than a blanket endorsement of stem-cell therapy. [29] Evidence for pluripotent stem-cell therapies remains constrained by substantial translational and safety challenges. [27] The Alzheimer's study was an early-phase randomized trial, not proof of established licensed treatment for Alzheimer's disease. [28]
- Mainstream view
- Stem-cell therapies are not one uniform treatment. Established hematopoietic stem-cell transplantation and a limited number of regulated cell or gene therapies are licensed for narrowly specified diseases and clinical circumstances. [26][27][29][32][33][34][36] Many other marketed or promoted stem-cell interventions remain investigational, lack adequate high-quality evidence, or are not approved by major regulators for the condition being treated. Therefore, the statement should not be interpreted as claiming that generic stem-cell therapy is broadly licensed or standard medical care. [25][28][35]
“stem cell therapy”
Rule: RSMo § 331.010
Jaban M Moore is not approved to offer Stem cell therapy for chronic illness within a Chiropractor scope of practice under Missouri State Board of Chiropractic Examiners.
Stem cell therapy for chronic illness
No specific health claims of theirs were cross-checked against the literature.
“stem cell therapy”
Rule: RSMo § 331.010
Manipulation
transcript · cited
Interviewing clinicians and having lived experience does not establish clinical expertise, diagnostic authority, or competence to synthesize treatment decisions for Lyme disease, autoimmune illness, lipedema, fertility, or stem-cell therapy. Likely motive: Borrow credibility from the number of interviews while positioning a patient and the host’s platform as a substitute for qualified medical evaluation.
“the most valuable person in chronic illness medicine isn’t a doctor — it’s a patient who’s interviewed 100 of them”
transcript · cited
The framing encourages distrust of ordinary specialist care and implies that patients need access to a special overarching interpretation, without showing evidence that standard multidisciplinary care cannot identify or manage these conditions. Likely motive: Create anxiety and perceived information scarcity that makes a private root-cause consultation seem necessary.
“something no single doctor could ever tell you — because no single doctor can see it”
transcript · cited
The wording presents non-antibiotic healing as an attractive alternative without identifying the intervention, its evidence, or the diagnostic circumstances. For confirmed Lyme disease, appropriate antibiotic treatment remains the evidence-based standard; delaying it can risk complications. Likely motive: Open a pathway to alternative protocols, consultations, or products while exploiting concern about conventional treatment.
“heal Lyme without antibiotics, and what she used instead”
transcript · cited
The description uses broad, serious disease themes and uncertainty to direct viewers into a one-to-one commercial consultation funnel. Likely motive: Convert distressed viewers into paid assessments, care plans, or follow-on services.
“Want to work 1:1 with Dr. Jaban to uncover the root cause of your health challenges? Book a Call with Our Team here”
Borrowed authority: Erika Schlick
guestCollaboration · conflation
Framed as IIN Certified Health Coach, cookbook author, podcast host, chronic-illness patient, interviewer of physicians, and founder of The Lipedema Summit. Brought on to discuss Chronic illness, Lyme disease, mold illness, autoimmune disease, lipedema, stem-cell therapy, and fertility. Topic sits outside the host's own scope.
“the most valuable person in chronic illness medicine isn’t a doctor — it’s a patient who’s interviewed 100 of them”
Commerce & grift map
The visible funnel is alarm and uncertainty about chronic illness, followed by a promise to uncover a hidden root cause and a booking call. No supplement or lab upsell is shown here, but the call could function as the entry point to paid protocols or other services; those downstream economics are not documented in the clip.
No paid-promotion disclosure appears on this youtube content. Viewers who arrive directly never learn the creator may be compensated by The Lipedema Summit.
No on-surface paid-promotion disclosure
vendorDisclosureGap
No paid-promotion disclosure appears on this youtube content. Viewers who arrive directly never learn the creator may be compensated by The Lipedema Summit.
No FTC-style compensation disclosure
compensationDisclosures · scan
The host promotes a paid or potentially paid one-to-one consultation funnel, but the price, payment terms, and downstream services are not shown.
coaching_program
Host self-funnel around guest content
guestCollaboration · selfFunnel
Host booking/consult links: https://consultation.drjabanmoore.com...
How the money flows
- Coaching or consult upsellUndisclosed The host promotes a paid or potentially paid one-to-one consultation funnel, but the price, payment terms, and downstream services are not shown. “Want to work 1:1 with Dr. Jaban to uncover the root cause of your health challenges? Book a Call with Our Team here”
“Want to work 1:1 with Dr. Jaban to uncover the root cause of your health challenges? Book a Call with Our Team here”
Credentials & scope
Glossary: Chiropractor (“Dr.”)
Learn: Is a chiropractor a medical doctor?
Credentials and scope reflect the dossier-wide determination for this subject, drawn from the strongest verified material across every analyzed source.
Stated: none · Likely: Chiropractor
Verified against the federal provider registry: D.C. · Chiropractor · MO license 2013013283.
Jaban Moore presents as a chiropractor, a real state-regulated credential with a narrower musculoskeletal and nervous-system scope. The site nevertheless markets broad disease-cause assessment and systemic detoxification concepts, creating credential inflation through specialty overreach.
- DC, Doctor of Chiropractic
A professional chiropractic degree and license qualifying the holder to practice chiropractic within state law; it is not an MD or DO medical degree.
A state chiropractic board typically permits evaluation and treatment of musculoskeletal and related nervous-system conditions using authorized chiropractic methods, but not general internal-medicine disease management, prescription pharmacology, or broad claims to diagnose and treat systemic disease.
Permitted scope vs advertised
Missouri State Board of Chiropractic Examiners · Confidence: high
Missouri chiropractors may examine, diagnose, adjust, manipulate, and treat malpositioned articulations and body structures using methods commonly taught in approved chiropractic colleges, with related advice on hygiene, nutrition, and sanitary measures. The scope excludes the practice of medicine and the administration or prescribing of drugs or medicine; treatment must be directed toward normal neuromuscular and musculoskeletal function and health.
What this license permits
- Spinal adjustment and manipulation
- Musculoskeletal evaluation and treatment
- Soft-tissue and rehabilitative care
- Headache care within musculoskeletal scope
10 of 10 advertised activities fall outside permitted scope.
| Advertised | Verdict |
|---|---|
| Lyme disease can be healed without antibiotics using an alternative approach. Rule: RSMo § 331.010 Claiming to heal Lyme disease with an alternative approach is treatment of a systemic infectious disease and is not affirmatively authorized as chiropractic treatment of malpositioned articulations or musculoskeletal structures. | Outside scope |
| Listed service Lyme disease Rule: RSMo § 331.010 Diagnosing Lyme disease is diagnosis of a systemic infectious disease and falls outside the statute’s limited chiropractic diagnostic authority. | Outside scope |
| Listed service Autoimmune disease Rule: RSMo § 331.010 Diagnosing an autoimmune disease is medical diagnosis of a systemic condition rather than diagnosis of a malpositioned articulation or body structure within the chiropractic definition. | Outside scope |
| Unspecified non-antibiotic Lyme treatment Rule: RSMo § 331.010 An unspecified treatment offered for Lyme disease is not affirmatively authorized because the statute limits chiropractic treatment to methods directed at neuromusculoskeletal and musculoskeletal function and excludes medical practice. | Outside scope |
| Stem cell therapy is presented as a chronic-illness treatment option under consideration. Rule: RSMo § 331.010 Presenting stem cell therapy as a chronic-illness treatment option invokes medical or biologic treatment outside the affirmative chiropractic authorization, even when described as under consideration. | Outside scope |
| GLP-1 medications, diet, and exercise will not affect lipedema. Rule: RSMo § 331.010 A definitive claim about medication efficacy and management of lipedema is medical disease-management advice, not chiropractic treatment directed to malpositioned articulations or musculoskeletal structures. | Outside scope |
| Listed service Mold-related illness Rule: RSMo § 331.010 Diagnosing mold-related illness concerns a systemic environmental or infectious condition and is not affirmatively authorized under Missouri’s chiropractic scope. | Outside scope |
| Listed service Lipedema Rule: RSMo § 331.010 Diagnosing lipedema is diagnosis of a systemic or vascular-adipose disorder rather than a chiropractic diagnosis of malpositioned articulations or structures treated to restore neuromusculoskeletal function. | Outside scope |
| Listed service Stem cell therapy Rule: RSMo § 331.010 Stem cell therapy is a biologic or medical treatment and is not affirmatively authorized by Missouri’s chiropractic scope statute. | Outside scope |
| Stem cell therapy for chronic illness Rule: RSMo § 331.010 Using or offering stem cell therapy for chronic illness is medical or biologic treatment beyond the authorized chiropractic methods and purposes. | Outside scope |
Sources: Missouri Board of Chiropractic Examiners — Statutes (official), Revised Statutes of Missouri § 331.010 — Practice of chiropractic, definition (official), Revised Statutes of Missouri § 331.110 — Patient records and diagnosis authorized by § 331.010 (official), Missouri Code of State Regulations, 20 CSR 2070-2.030 — Diagnostic and Adjunctive Procedures (official)
Validated associated properties
Surfaces tied to this Doc Bro by domain, branding, or funnel routing. Third-party platforms are labeled as routes, not as owned properties.
Analyzed
- OwnedOfficial site (drjabanmoore.com)
- OwnedJaban M Moore clinic / principal site (synergizedsupps.com)
- Operated funnelPractice site (redefiningwellnesscenter.com)
- Linked entityLinked commerce or practice (m.drjaban.com)
Funnel routes (third-party)
- Hosted routeFunnel route on myshopify.com
- Hosted routeFunnel route on amazon.com
Tip the jar
Report useful? Optional tips help keep scans, archives, and literature cross-checks running. They never change conclusions.
Submission kwC_zq36_9f_m3p061Iam
Fight disinformation
Log a public thread where Jaban M Moore is spreading nonsense, get a copy-paste reply with this report link.
Reply snippets
Before you buy the protocol: Dr. Trust Me Bro fact-checked Jaban M Moore's claims with peer-reviewed sources, https://drtrustmebro.com/analyze/kwC_zq36_9f_m3p061Iam. White-coat charisma isn't evidence.
Full DTMB scan on Jaban M Moore: https://drtrustmebro.com/analyze/kwC_zq36_9f_m3p061Iam
Drop these in YouTube comments, Reddit threads, and forums, link back to this scan, not vibes.
Recent mentions (this doc)
- Other
Catching the Red Flags, with Michael Rubino
Interview page that features his mold and toxin claims.
- YouTube
Stop Masking Symptoms and Get to the Root Cause of Your Illness
Interview appearance with an open comment thread.
- Other
Episode 52: The Dangers of Chemical Toxicities with Jaban Moore
Podcast interview page where the pitch reaches a new audience.
- YouTube
Nervous System Dysregulation: The Invisible Barrier to Recovery
One of Jaban M Moore's own recent posts. The comment thread is where this pitch spreads, reply there with the report link.
- YouTube
How Dr. Jill Carnahan Uses Peptides for Mold, MCAS, and Chronic Illness
One of Jaban M Moore's own recent posts. The comment thread is where this pitch spreads, reply there with the report link.
Know someone who can help?
If you think someone has firsthand information about Jaban M Moore, send them an encouraging note. We email a short, respectful message with this report and clear instructions on how to write in, on the record or anonymously.
Whambulance
Challenge this scan or Wall of Fame entry for Jaban M Moore. Public log, not legal arbitration.
Public challenge log
No posted Wall of Fame challenges linked yet.
Challenges are public on the Wall of Fame card. DTMB does not remove entries for hurt feelings, primary sources or copy corrections only.
File a challenge
Include in your email:
- Doc Bro ID: LHGCVS_CZpjf-As5HKrmZ
- Wall entry: /influencer/LHGCVS_CZpjf-As5HKrmZ
- Analysis ID: kwC_zq36_9f_m3p061Iam
- Source: https://www.youtube.com/watch?v=yT3ENX1G7zo
- Why this entry or scan should change
- Supporting links (one per line)
- Your business email (for verified disputes)
Verified challenges are posted publicly on the report. Public log, not legal arbitration.
Citations
Peer-reviewed and index sources cited in this report.
- [1] What are the most up to date guideline recommendations for the ...
- [2] I D S A F E AT U R E S
- [3] Clinical Practice Guidelines by the Infectious Diseases Society of ...
- [4] Clinical Assessment, Treatment, and Prevention of Lyme ...
- [5] A clinical approach to diagnosis of autoimmune encephalitis.
- [6] Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment.
- [7] Diagnosis and management of ANCA-associated vasculitis.
- [8] Autoimmune Encephalitis Misdiagnosis in Adults.
- [9] Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial.
- [10] Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting.
- [11] Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management.
- [12] Autoimmune encephalitis: clinical spectrum and management.
- [13] Biologic therapy for autoimmune diseases: an update - PMC
- [14] Immunosuppressive Treatment Regimens in Autoimmune ...
- [15] 2026 British Society for Rheumatology guideline for the ...
- [16] Innovations in immunotherapy for autoimmune diseases - PMC
- [17] Tirzepatide as a Potential Disease-Modifying Therapy in ...
- [18] Table 2.
- [19] SAT-685 Low-dose Tirzepatide For The Treatment Of Patient With ...
- [20] The Potential Role of Glucagon-like Peptide-1 Receptor ...
- [21] Mold - CDC
- [22] WHO Guidelines for Indoor Air Quality: Dampness and Mould
- [23] WHO guidelines for indoor air quality: dampness and mould
- [24] WHO guidelines for indoor air quality : dampness and mould
- [25] Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial.
- [26] Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access.
- [27] Pluripotent Stem Cell-Based Cell Therapy-Promise and Challenges.
- [28] Allogeneic mesenchymal stem cell therapy with laromestrocel in mild Alzheimer's disease: a randomized controlled phase 2a trial.
- [29] Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update.
- [30] Paroxysmal nocturnal haemoglobinuria.
- [31] Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia.
- [32] Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours.
- [33] Major breakthroughs in hematopoietic stem cell ...
- [34] Use of Biosimilar Granulocyte Colony-Stimulating Factor for ... - PMC
- [35] FDA approves first stem-cell therapy - Oxford Academic
- [36] TCRαβ/CD19 Depletion of Stem Cell Grafts for Transplant